ZIM LABORATORIES
Quarterly Results Analysis [Dec2023]
ZIM LABORATORIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹96 Cr | ₹86 Cr | ₹67 Cr | ₹105 Cr | ₹101 Cr | ₹99 Cr | ₹93 Cr | ₹105 Cr |
Expenses | ₹85 Cr | ₹77 Cr | ₹63 Cr | ₹90 Cr | ₹88 Cr | ₹87 Cr | ₹82 Cr | ₹90 Cr |
Operating Income | ₹12 Cr | ₹9 Cr | ₹5 Cr | ₹15 Cr | ₹13 Cr | ₹12 Cr | ₹11 Cr | ₹15 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹7 Cr | ₹5 Cr | ₹0 Cr | ₹10 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹11 Cr |
Profit After Tax | ₹5 Cr | ₹4 Cr | ₹0 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹7 Cr |
EPS | ₹0.98 | ₹0.85 | ₹0.05 | ₹1.49 | ₹1.35 | ₹1.12 | ₹1.06 | ₹1.44 |
Industry Peers & Returns | 1W | 1M | 1Y |
ZIM LABORATORIES | -0.6% | -14.4% | 27.4% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
ZIM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 12.20 % |
Y-o-Y | -4.63 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹96 Cr | 12.20 | |
Sep2023 | ₹86 Cr | 27.26 | |
Jun2023 | ₹67 Cr | -36.02 | |
Mar2023 | ₹105 Cr | 4.40 | |
Dec2022 | ₹101 Cr | 1.58 | |
Sep2022 | ₹99 Cr | 7.17 | |
Jun2022 | ₹93 Cr | -11.72 | |
Mar2022 | ₹105 Cr | - |
ZIM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 23.70 % |
Y-o-Y | -11.89 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹12 Cr | 23.70 | |
Sep2023 | ₹9 Cr | 93.04 | |
Jun2023 | ₹5 Cr | -68.74 | |
Mar2023 | ₹15 Cr | 18.03 | |
Dec2022 | ₹13 Cr | 6.77 | |
Sep2022 | ₹12 Cr | 9.64 | |
Jun2022 | ₹11 Cr | -24.21 | |
Mar2022 | ₹15 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.31 % |
Y-o-Y | -7.63 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 11.98% | 10.31 | |
Sep2023 | 10.86% | 51.68 | |
Jun2023 | 7.16% | -51.16 | |
Mar2023 | 14.66% | 13.03 | |
Dec2022 | 12.97% | 5.11 | |
Sep2022 | 12.34% | 2.32 | |
Jun2022 | 12.06% | -14.10 | |
Mar2022 | 14.04% | - |
ZIM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 15.35 % |
Y-o-Y | -27.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹5 Cr | 15.35 | |
Sep2023 | ₹4 Cr | 1,735.84 | |
Jun2023 | ₹0 Cr | -96.88 | |
Mar2023 | ₹7 Cr | 9.65 | |
Dec2022 | ₹7 Cr | 21.15 | |
Sep2022 | ₹5 Cr | 5.83 | |
Jun2022 | ₹5 Cr | -26.77 | |
Mar2022 | ₹7 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 2.90 % |
Y-o-Y | -24.01 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 4.97 % | 2.90 | |
Sep2023 | 4.83 % | 1,320.59 | |
Jun2023 | 0.34 % | -95.05 | |
Mar2023 | 6.87 % | 5.05 | |
Dec2022 | 6.54 % | 19.34 | |
Sep2022 | 5.48 % | -1.26 | |
Jun2022 | 5.55 % | -17.04 | |
Mar2022 | 6.69 % | - |
ZIM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 15.29 % |
Y-o-Y | -27.41 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.98 | 15.29 | |
Sep2023 | ₹0.85 | 1,600.00 | |
Jun2023 | ₹0.05 | -96.64 | |
Mar2023 | ₹1.49 | 10.37 | |
Dec2022 | ₹1.35 | 20.54 | |
Sep2022 | ₹1.12 | 5.66 | |
Jun2022 | ₹1.06 | -26.39 | |
Mar2022 | ₹1.44 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD